Guardant Health Inc (MIL:1GH)
€ 138.3 (0%) Market Cap: 18.64 Bil Enterprise Value: 19.17 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Guardant Health Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 11:45PM GMT
Release Date Price: €90.22 (-4.25%)
Casey Woodring
JPMorgan Chase & Co - Analyst

All right, great. I think we can get started here. Hi everybody. My name's Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. Pleased to introduce Garden Health and the management team of the Garden Health here. We're going to do a presentation followed by Q&A afterwards. Helmy, take it away.

Helmy Eltoukhy
Guardant Health Inc - Chairperson of the Board, Co-Chief Executive Officer

Awesome.

Thank you, Casey, and good afternoon, everyone, and thank you for joining us today.

Please note our forward-looking statement.

At Garden, everything we do is guided by a simple but ambitious mission to give every person more time free from disease.

We began that mission over 10 years ago, pioneering the first liquid biopsy test for cancer therapy selection through countless innovations, and we have expanded to help even more patients with our offerings for occurrence monitoring and cancer screening.

To date we have tested over 1 million

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot